Iradimed Corp. (IRMD) Tops Q2 EPS by 5c, beats revenue

Iradimed Corp. (NASDAQ: IRMD) reported Q2 EPS of $0.36, $0.05 better than the analyst estimate of $0.31. Revenue for the quarter came in at $16.13 million versus the consensus estimate of $15.66 million.

For earnings history and earnings-related data on Iradimed Corp. (IRMD) click here.

You May Also Be Interested In

• Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
• Delta Air Lines stock climbs on earnings beat and strong guidance
• Goldman Sachs reports global fund inflows for week of July 8